The Center for Global Health Policy & the HIV Medicine Association teamed up last week for a series of advocacy meetings on Capitol Hill, drawing attention to the domestic and global fight against HIV/AIDS. The meetings—featuring top HIV/AIDS doctors and researchers—come at a critical moment, with Congress set to make vital funding decisions about HIV/AIDS […]
Starting Wednesday, John Donnelly, a former reporter with the Boston Globe, will be live blogging in this space from the HIV/AIDS Implementers’ Meeting. The conference will delve into the latest research and program innoviations on a gamut of topics–from male circumcision to HIV/TB co-infection to program planning amid the current economic uncertainty. Coming as Congress considers funding for […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]